- Home
- IPHA vs FCCO Comparison
IPHA vs FCCO Comparison
Compare IPHA & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- FCCO
- Stock Information
- Founded
- IPHA 1999
- FCCO 1994
- Country
- IPHA France
- FCCO United States
- Employees
- IPHA 179
- FCCO N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- FCCO Major Banks
- Sector
- IPHA Health Care
- FCCO Finance
- Exchange
- IPHA Nasdaq
- FCCO Nasdaq
- Market Cap
- IPHA 192.7M
- FCCO 166.4M
- IPO Year
- IPHA 2019
- FCCO 1998
- Fundamental
- Price
- IPHA $2.34
- FCCO $20.99
- Analyst Decision
- IPHA Strong Buy
- FCCO Buy
- Analyst Count
- IPHA 1
- FCCO 1
- Target Price
- IPHA $11.50
- FCCO $21.00
- AVG Volume (30 Days)
- IPHA 5.8K
- FCCO 18.4K
- Earning Date
- IPHA 09-12-2024
- FCCO 10-16-2024
- Dividend Yield
- IPHA N/A
- FCCO 2.85%
- EPS Growth
- IPHA N/A
- FCCO N/A
- EPS
- IPHA N/A
- FCCO 1.42
- Revenue
- IPHA $68,134,188.00
- FCCO $59,227,000.00
- Revenue This Year
- IPHA N/A
- FCCO N/A
- Revenue Next Year
- IPHA $105.84
- FCCO $9.86
- P/E Ratio
- IPHA N/A
- FCCO $14.92
- Revenue Growth
- IPHA 6.88
- FCCO N/A
- 52 Week Low
- IPHA $1.81
- FCCO $15.40
- 52 Week High
- IPHA $3.15
- FCCO $23.30
- Technical
- Relative Strength Index (RSI)
- IPHA 56.39
- FCCO 52.24
- Support Level
- IPHA $2.22
- FCCO $21.23
- Resistance Level
- IPHA $2.41
- FCCO $22.20
- Average True Range (ATR)
- IPHA 0.14
- FCCO 0.60
- MACD
- IPHA 0.00
- FCCO -0.10
- Stochastic Oscillator
- IPHA 82.35
- FCCO 49.50
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About FCCO First Community Corporation
First Community Corp is a bank holding company, which provides commercial banking services. It is engaged in the general commercial and retail banking business characterized by personalized service and local decision making, emphasizing the banking needs of small to medium-sized businesses, professional concerns, and individuals. It operates through following segments: Commercial and Retail Banking; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate. It offers checking, savings, money market, individual retirement, and certificates of deposit accounts. Its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others.